{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:41:10Z","timestamp":1790872870005,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-PG-0606-1049"],"award-info":[{"award-number":["RP-PG-0606-1049"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.schres.2017.12.012","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T00:14:44Z","timestamp":1514074484000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Complement system biomarkers in first episode psychosis"],"prefix":"10.1016","volume":"204","author":[{"given":"Maja","family":"Kopczynska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-3550","authenticated-orcid":false,"given":"Wioleta","family":"Zelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gaughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.12.012_bb0005","first-page":"1","article-title":"Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels","author":"Akcan","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.schres.2017.12.012_bb0010","first-page":"1486","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andr\u00e9asson","year":"1987","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.schres.2017.12.012_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","article-title":"Complement activation in experimental and human temporal lobe epilepsy","volume":"26","author":"Aronica","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.schres.2017.12.012_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2017.12.012_bb0025","first-page":"19","article-title":"The psychosis screening questionnaire","volume":"5","author":"Bebbington","year":"1995","journal-title":"Int. J. Method. Psych."},{"key":"10.1016\/j.schres.2017.12.012_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2017.12.012_bb0035","first-page":"65","article-title":"Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital","volume":"56","author":"de Leon","year":"2002","journal-title":"Schizophr."},{"key":"10.1016\/j.schres.2017.12.012_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2017.12.012_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-244X-13-50","article-title":"The nature of relapse in schizophrenia","volume":"13","author":"Emsley","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2017.12.012_bb0050","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.24316","article-title":"C-reactive protein and systemic lupus erythematosus","volume":"59","author":"Gaitonde","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.schres.2017.12.012_bb0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1749-6632.1987.tb35829.x","article-title":"Clinical and laboratory evidence of autoimmunity in acute schizophrenia","volume":"496","author":"Ganguli","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2017.12.012_bb0060","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2017.12.012_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","article-title":"Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests","volume":"45","author":"Greiner","year":"2000","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.schres.2017.12.012_bb0070","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2215-0366(15)00152-2","article-title":"Does tobacco use cause psychosis? Systematic review and meta-analysis","volume":"2","author":"Gurillo","year":"2015","journal-title":"Lancet Psychiat."},{"key":"10.1016\/j.schres.2017.12.012_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2004.10.024","article-title":"Classical pathway complement activity in schizophrenia","volume":"374","author":"Hakobyan","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2017.12.012_bb0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.schres.2017.12.012_bb0085","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/1352458512438238","article-title":"Systemic complement profiling in multiple sclerosis as a biomarker of disease state","volume":"18","author":"Ingram","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.schres.2017.12.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012740","article-title":"Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures","volume":"5","author":"Jamali","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2017.12.012_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/apt.6.5.327","article-title":"Cigarette smoking and schizophrenia","volume":"6","author":"Kelly","year":"2000","journal-title":"Adv. Psychiatr. Treat."},{"key":"10.1016\/j.schres.2017.12.012_bb0100","first-page":"1007","article-title":"Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement","volume":"5","author":"Kew","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.schres.2017.12.012_bb0105","first-page":"129","article-title":"Cytokine changes and tryptophan metabolites in medication-na\u00efve and medication-free schizophrenic patients","volume":"9","author":"Kim","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2017.12.012_bb0110","first-page":"370","article-title":"Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal","volume":"19","author":"Kirch","year":"1993","journal-title":"Schizophr."},{"key":"10.1016\/j.schres.2017.12.012_bb0115","first-page":"374","article-title":"Effects of cigarette smoking on blood levels of leukotrienes and plasma levels of complements C3A and C5A in healthy volunteers","volume":"43","author":"Kobayashi","year":"1988","journal-title":"Arch. Environ. Heal. An. Int. J."},{"key":"10.1016\/j.schres.2017.12.012_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajmg.b.32195","article-title":"HLA associations in schizophrenia: are we re-discovering the wheel?","volume":"165B","author":"Kodavali","year":"2014","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2017.12.012_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157015909787602805","article-title":"Implication of complement system and its regulators in Alzheimers disease","volume":"7","author":"Kolev","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.schres.2017.12.012_bb0130","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1039\/c2mb25158b","article-title":"Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia","volume":"8","author":"Li","year":"2012","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.schres.2017.12.012_bb0135","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.1038\/srep18713","article-title":"Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2017.12.012_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.schres.2017.12.012_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1358\/dnp.2008.21.4.1213349","article-title":"The complement system in schizophrenia","volume":"21","author":"Mayilyan","year":"2008","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.schres.2017.12.012_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1192\/apt.bp.114.012872","article-title":"Immune abnormalities across psychiatric disorders: clinical relevance","volume":"21","author":"Mondelli","year":"2015","journal-title":"BJPscyh. Adv."},{"key":"10.1016\/j.schres.2017.12.012_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.schres.2017.12.012_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.12.012_bb0165","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.schres.2017.12.012_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamapsychiatry.2013.896","article-title":"Gestational influenza and bipolar disorder in adult offspring","volume":"70","author":"Parboosing","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.schres.2017.12.012_bb0175","first-page":"538","article-title":"Neuropil pruning in early-course schizophrenia: immunological, clinical, and neurocognitive correlates","volume":"1","author":"Prasad","year":"2016","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.schres.2017.12.012_bb0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.schres.2017.12.012_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.10100","article-title":"Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort","volume":"18","author":"Ritchie","year":"2004","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.schres.2017.12.012_bb0190","first-page":"L259","article-title":"Complement activation by cigarette smoke","volume":"260","author":"Robbins","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.schres.2017.12.012_bb2015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1192\/bjp.bp.110.082925","article-title":"OPCRIT+: an electronic system for psychiatric diagnosis and data collection in clinical and research settings","author":"Rucker","year":"2011","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.schres.2017.12.012_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnins.2014.00019","article-title":"The impact of environmental factors in severe psychiatric disorders","volume":"8","author":"Schmitt","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.schres.2017.12.012_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.schres.2017.12.012_bb0205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg3706","article-title":"Statistical power and significance testing in large-scale genetic studies","volume":"15","author":"Sham","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.schres.2017.12.012_bb0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.schres.2017.12.012_bb0215","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.schres.2017.12.012_bb0220","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ntr\/ntp144","article-title":"Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers","volume":"11","author":"Sunyer","year":"2009","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.schres.2017.12.012_bb0225","first-page":"83","article-title":"Gene-environment interactions in mental disorders","volume":"3","author":"Tsuang","year":"2004","journal-title":"World Psychiat."},{"key":"10.1016\/j.schres.2017.12.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.4","article-title":"Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies","volume":"7","author":"van Kesteren","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2017.12.012_bb0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2017.12.012_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2013\/510402","article-title":"Biomarkers in schizophrenia: a brief conceptual consideration","volume":"35","author":"Weickert","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.schres.2017.12.012_bb0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.psc.2007.04.010","article-title":"Understanding and treating "first-episode" schizophrenia","volume":"30","author":"Weiden","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.schres.2017.12.012_bb0250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(96)00037-0","article-title":"Acute phase proteins in male Chinese schizophrenic patients in Singapore","volume":"22","author":"Wong","year":"1996","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417307648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417307648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:43:42Z","timestamp":1565333022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417307648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":51,"alternative-id":["S0920996417307648"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.12.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement system biomarkers in first episode psychosis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}